Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 9,238 | 16,955 | 13,799 | 13,294 | 11,489 |
| Gross Profit | 9,238 | 16,955 | 13,799 | 13,294 | 11,489 |
| Operating Expenses | 35,312 | 61,821 | 59,838 | 62,408 | 50,254 |
| Operating Income | -26,074 | -44,866 | -46,039 | -49,114 | -38,765 |
| Interest Expense | 2,705 | 2,755 | 2,751 | 2,748 | 2,744 |
| Other Income | 45,679 | 957 | 1,464 | 3,641 | 3,236 |
| Pre-tax Income | 16,900 | -46,664 | -47,326 | -48,221 | -38,273 |
| Net Income Continuous | 16,900 | -46,664 | -47,238 | -48,221 | -38,273 |
| Net Income | $16,900 | $-46,664 | $-47,238 | $-48,221 | $-38,273 |
| EPS Basic Total Ops | 0.05 | -0.20 | -0.21 | -0.21 | -0.17 |
| EPS Basic Continuous Ops | 0.05 | -0.20 | -0.20 | -0.21 | -0.17 |
| EPS Diluted Total Ops | 0.08 | -0.20 | -0.21 | -0.21 | -0.17 |
| EPS Diluted Continuous Ops | 0.05 | -0.20 | -0.20 | -0.21 | -0.17 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.20 | -0.21 | -0.21 | -0.17 |
| EBITDA(a) | $-21,259 | $-45,039 | $-46,643 | $-50,231 | $-40,251 |